|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 98962348.3 (espacenet) (Federated) (European Patent Register), 19981113 | Patent/reg. no. and date | DK/EP 1030667, 20050302 | Publication date | 20000830 | Priority no. and date | EP 97203548, 19971114 | EP pub. no. and date |
EP 1030667 20000830 | Effective date | | Applicant/owner | N.V. Organon, Kloosterstraat 6
5349 AB Oss, NL | Applicant ref. no. | 80304 | Inventor | ANDREWS, John, Stuart, 7 Rowan Grove
Quarter
Hamilton ML3 7TT, GB | Representative | CHAS. HUDE A/S, Langebrogade 3B, 1411 København K, DK | Opponent | | IPC Class | A61K 31/55 (2006.01) , A61P 11/16 (2006.01) | Title | Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af søvnapnø | Int. application no. | EP1998007330 | Int. publication no. | WO1999025356 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |